Using data obtained through freedom of information requests to 152 NHS foundation trusts in England, 105 of which replied, membership organisation the Cannabis Industry...
A working group for CBD companies has been established by the Cannabis Industry Council (CIC), which will run alongside groups dedicated to hemp, standards,...
Psilocybin-based active pharmaceutical ingredient (API) KRN-101, developed by Albert Labs, is set for its first in-human study.
The Vancouver-based pharmaceutical drug development company has signed...
Results of a trial examining whether cannabidiol (CBD) makes cannabis safer, led by scientists from King's College, London, and funded by the Medical Research...
Germany’s health minister, Professor Dr Karl Lauterbach, has launched his government’s plan to legalise recreational cannabis for adults, noting that banning cannabis has had...